Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2001-1-24
pubmed:abstractText
Recently, the role of various cytokines in the pathogenesis of chronic rhinosinusitis has come under investigation. Various studies have reported increased levels of interleukin-3, interleukin-4, interleukin-5, interleukin-13, and granulocyte macrophage-colony stimulating factor in the sinonasal mucosa of patients with chronic rhinosinusitis. The present study investigated the levels of pro-inflammatory cytokines, including interleukin-1 beta (IL-1 beta), interleukin-5 (IL-5), interleukin-6 (IL-6) interleukin-8 (IL-8), and tumor necrosis factor-alpha (TNF-alpha), in the sinonasal mucosa of patients with chronic rhinosinusitis, and evaluated the response of these cytokines to oral corticosteroids. Chronic rhinosinusitis subjects (n = 15) and control subjects (n = 9) underwent nasal endoscopy and biopsy of the sinonasal mucosa. Chronic rhinosinusitis subjects were subsequently treated with a 10-day tapering dose of prednisone followed by a second sinonasal endoscopic exam and biopsy. Mucosal biopsy specimens were immunostained for IL-1 beta, IL-5, IL-6, IL-8, and TNF-a. In chronic rhinosinusitis subjects, mucosal levels of IL-1 beta, IL-6, IL-8, and TNF-alpha were significantly elevated when compared with control subjects, and levels of IL-5 demonstrated a strong trend toward elevation. In posttreatment chronic rhinosinusitis subjects, levels of IL-6 were significantly decreased when compared with pretreatment levels, and TNF-alpha levels demonstrated a significant trend toward reduction. These findings support the hypothesis that the inflammatory response in chronic rhinosinusitis is associated with elevated levels of pro-inflammatory cytokines, and suggest that oral corticosteroids may exert a beneficial effect by significantly reducing the levels of IL-6 and TNF-alpha.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1050-6586
pubmed:author
pubmed:issnType
Print
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
367-73
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11197112-Administration, Oral, pubmed-meshheading:11197112-Adult, pubmed-meshheading:11197112-Aged, pubmed-meshheading:11197112-Aged, 80 and over, pubmed-meshheading:11197112-Anti-Inflammatory Agents, pubmed-meshheading:11197112-Chronic Disease, pubmed-meshheading:11197112-Cytokines, pubmed-meshheading:11197112-Endoscopy, pubmed-meshheading:11197112-Female, pubmed-meshheading:11197112-Humans, pubmed-meshheading:11197112-Immunohistochemistry, pubmed-meshheading:11197112-Interleukin-1, pubmed-meshheading:11197112-Interleukin-5, pubmed-meshheading:11197112-Interleukin-8, pubmed-meshheading:11197112-Male, pubmed-meshheading:11197112-Middle Aged, pubmed-meshheading:11197112-Nasal Polyps, pubmed-meshheading:11197112-Prednisone, pubmed-meshheading:11197112-Rhinitis, pubmed-meshheading:11197112-Sinusitis, pubmed-meshheading:11197112-Tumor Necrosis Factor-alpha
pubmed:articleTitle
Interleukin-1 beta, interleukin-5, interleukin-6, interleukin-8, and tumor necrosis factor-alpha in chronic sinusitis: response to systemic corticosteroids.
pubmed:affiliation
Division of Otolaryngology, Walter Reed Army Medical Center, Washington, DC, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S.